A living model that responds rapidly to emerging research, using trusted standards for evidence synthesis and clinical guidelines, powered by AI.
Traditional systematic reviews are out of date before they're published. In oncology, where a single trial can redefine first-line treatment overnight, static guidelines cost lives. LISR changes that.
AI monitors PubMed, EMBASE, and trial registries 24/7, new trials flagged within hours of publication.
Machine learning extracts outcomes using validated pipelines, 10× faster than manual review.
International oncology experts review, grade, and contextualise every update before it goes live.
Every review is freely available to clinicians and patients worldwide, no paywalls, no barriers.
Get notified when new reviews, evidence updates, or guideline revisions are published.
No spam. Unsubscribe any time.